Search KLH Site
Find Articles by Tags
Addiction (18) Adjuvant - Alum (1) Adjuvant - GPI-0100 (1) Adjuvant - IL-4 (9) Adjuvant GM-CSF (16) Adjuvant KLH (4) Adjuvant Oil / Surfactant (4) Adjuvant QS-21 (25) Age & Physical Activity (3) Allergen-specific immunotherapy (1) Allergy – Pollen (2) Alzheimer's Disease (3) Antibody Response (35) Antibody Response IgA (14) Antibody Response IgE (6) Antibody Response IgG (106) Antibody Response IgM (71) Antibody Response IgY (1) APEC (1) Assay - Bioassay (2) Assay - Carbohydrate Microarray (1) Assay - ELISA (55) Assay - ELISPOT (7) Assay - Immunoassay (8) Assay - InVitro (18) Assay - InVivo (1) Atopic Dermatitis (1) Autoimmune Disease (1) B-epitope (1) Bone Marrow Transplant (6) Cancer (6) Cancer - Bladder (16) Cancer - Brain & CNS (8) Cancer - Breast (15) Cancer - Cervical (1) Cancer - Colorectal (10) Cancer - Esophageal (1) Cancer - Female Reproductive (7) Cancer - Leukemia (2) Cancer - Lung (4) Cancer - Lymphoma (25) Cancer - Melanoma (37) Cancer - Mesothelioma (1) Cancer - Myeloma (15) Cancer - Other (2) Cancer - Ovarian (3) Cancer - Pancreas (1) Cancer - Pediatric (3) Cancer - Peritoneal (2) Cancer - Prostate (9) Cancer - Renal (13) Cancer - Sarcoma (2) Clostridium difficile (5) Crohn's Disease (2) Cross-Reactive Antigens (6) Delayed-type hypersensitivity response (1) Dendritic Cell (66) Developmental (10) Diabetes (2) Disease Resistence (1) DNP-Ficoll (2) DTH (67) Environmental (15) Escherichia coli (1) Fingolimod (Gilenya) (1) Healthy Volunteers (18) HealthyAntibody Response - IgA (1) Hepatitis (2) HIV (11) HPV (3) Husbandry (3) Hypertension (1) id-KLH (29) IL 1 (4) IL 12 (2) IL 15 (1) IL 2 (10) IL 5 (1) IL 6 (1) IL 7 (1) Immune Disease - Autoimmune (13) Immune Disease - Primary (2) Immune Disease – Secondary (1) Immune Response - Cellular (187) Immune Response - Humoral (259) Immune Response Humoral (2) Immunotoxicity (37) Infection (1) Infectious Disease (5) Inflammatory Disease (1) Intradermal KLH (1) Kidney (1) KLH-BEC2 (1) KLH-BP16 (1) KLH-BPO (1) KLH-Conjugate (69) KLH-EGFR (2) KLH-FITC (1) KLH-Ganglioside (16) KLH-Globo H (7) KLH-GM2 (1) KLH-hD1 (1) KLH-HGP-30 (1) KLH-IL (1) KLH-Kinoid (8) KLH-Lewis Y (3) KLH-MUC (8) KLH-Oxycodone (2) KLH-sTn (9) KLH-TF (5) KLH-TN (3) Model - Canine (6) Model - Guinea Pig (10) Model - Livestock (10) Model - Mouse (73) Model - Other (32) Model - Primate (12) Model - Rat (51) Multiple Sclerosis (1) Nasal (3) Natrural Antibody (1) Neonatal (2) NK Cells (1) NSAID (1) Oral KLH (9) Oxycodone (3) Parasitic Disease (6) Pediatric (1) Plant-made (2) PLNA (1) Population Density (3) Psoriasis (1) Review Article (2) Rheumatoid Arthritis (11) Rituximab (Rituxan) (4) Russian thistle (1) Sal k 1 (1) Stress (8) Systemic Lupus Erythematosus (SLE) (7) TACA (2) TDAR (127) Therapeutics - KLH Alone (15) Transplant (6) Ultra Violet radiation (1) Uveitis (1) VEGF (3) Veterinary (1)
Terms and Privacy

KLH in Publications

Publications of scientific research involving KLH. Abstracts or full text articles are available by link to outside sites. If you know of a KLH-related publication that is not yet on KLH Site™, let us know.

(in order by date)

Entries in Therapeutics - KLH Alone (15)

Monday
Jul112011

Hemocyanins as immunostimulants

Del Campo M, Arancibia S, Nova E, Salazar F, González A, Moltedo B, De Ioannis P, Ferreira J, Manubens A, Becker MI.

Rev Med Chil. 2011 Feb;139(2):236-46. Epub 2011 Jul 11

Friday
Oct012004

Superficial bladder cancer therapy

Emmanuel Schenkman, M.D. and Donald L. Lamm, M.D.

ScientificWorldJ (2004) 4 (S1), 387–399

Saturday
Nov012003

Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's esophageal adenocarcinoma.

McFadden DW, Riggs DR, Jackson BJ, Vona-Davis L

Am J Surg. 2003 Nov;186(5):552-5.

Wednesday
Oct012003

Laboratory and clinical experience with keyhole limpet hemocyanin (Immucothel(r)) in superficial bladder cancer

Sunday
Dec012002

In vitro anticancer effects of a novel immunostimulant: keyhole limpet hemocyanin

Riggs DR, Jackson B, Vona-Davis L, McFadden D.

J Surg Res. 2002 Dec;108(2):279-84

Thursday
Oct032002

Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial.

Märten A, Flieger D, Renoth S, Weineck S, Albers P, Compes M, Schöttker B, Ziske C, Engelhart S, Hanfland P, Krizek L, Faber C, von Ruecker A, Müller S,Sauerbruch T, Schmidt-Wolf IG.

Cancer Immunol Immunother. 2002 Dec;51(11-12):637-44. Epub 2002 Oct 3.

Sunday
Oct012000

Keyhole limpet hemocyanin for carcinoma in situ of the bladder: a long-term follow-up study

Jurincic-Winkler CD, Metz KA, Beuth J, Klippel KF.

Eur Urol. 2000;37 Suppl 3:45-9

Friday
Sep012000

Keyhole limpet hemocyanin immunotherapy of bladder cancer: laboratory and clinical studies

Lamm DL, Dehaven JI, Riggs DR.

Eur Urol. 2000;37 Suppl 3:41-4

Tuesday
Aug012000

Efficacy of prophylactic Immucothel in patients pretreated with conventional drugs to prevent recurrence of superficial bladder carcinoma

Echarti C, Jurincic-Winkler CD, Klippel KF.

Eur Urol. 2000;37 Suppl 3:50-3

Saturday
Jan012000

Keyhole limpet haemocyanin in experimental bladder cancer: literature review and own results

Linn JF, Black P, Derksen K, Rübben H, Thüroff JW

Eur Urol. 2000;37 Suppl 3:34-40

Monday
Sep011997

Immunotherapy of bladder cancer

Monday
Jul011996

Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma

Jurincic-Winkler CD, von der Kammer H, Beuth J, Scheit KH, Klippel KF

Anticancer Res. 1996 Jul-Aug;16(4A):2105-10

Sunday
Oct011995

Efficacy of local Bacillus Calmette-Guérin treatment in superficial bladder cancer relapsing under Keyhole-Limpet Hemocyanin immunotherapy.

Jurincic-Winkler C, Engelmann U, Beuth J, Klippel KF

Zentralbl Bakteriol. 1995 Oct;282(4):409-15

Monday
May011995

Keyhole-limpet hemocyanin immunotherapy in the bilharzial bladder: a new treatment modality? Phase II trial: superficial bladder cancer

Wishahi MM, Ismail IM, Ruebben H, Otto T.

J Urol. 1995 Mar;153(3 Pt 2):926-8

Sunday
Jan011995

Urinary interleukin-1 alpha levels are increased by intravesical instillation with keyhole limpet hemocyanin in patients with superficial transitional cell carcinoma of the bladder

Jurincic-Winkler CD, Gallati H, Alvarez-Mon M, Sippel J, Carballido J, Klippel KF

Eur Urol. 1995;28(4):334-9